RS50680B - Karbamatna jedinjenja za upotrebu u sprečavanju i lečenju bipolarnih poremećaja - Google Patents

Karbamatna jedinjenja za upotrebu u sprečavanju i lečenju bipolarnih poremećaja

Info

Publication number
RS50680B
RS50680B YUP-680/03A YUP68003A RS50680B RS 50680 B RS50680 B RS 50680B YU P68003 A YUP68003 A YU P68003A RS 50680 B RS50680 B RS 50680B
Authority
RS
Serbia
Prior art keywords
formula
enantiomer
phenyl
alkyl
group
Prior art date
Application number
YUP-680/03A
Other languages
English (en)
Serbian (sr)
Inventor
Boyu Zhao
Carlos Plata-Salman
Roy Twyman
Yong Moon Choi
Robert Gordon
Original Assignee
Ortho-Mcneil Pharmaceutical Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho-Mcneil Pharmaceutical Inc. filed Critical Ortho-Mcneil Pharmaceutical Inc.
Publication of YU68003A publication Critical patent/YU68003A/sh
Publication of RS50680B publication Critical patent/RS50680B/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
YUP-680/03A 2001-02-27 2002-02-21 Karbamatna jedinjenja za upotrebu u sprečavanju i lečenju bipolarnih poremećaja RS50680B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27168001P 2001-02-27 2001-02-27
US10/081,606 US7122576B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating bipolar disorder

Publications (2)

Publication Number Publication Date
YU68003A YU68003A (sh) 2006-08-17
RS50680B true RS50680B (sr) 2010-06-30

Family

ID=26765743

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-680/03A RS50680B (sr) 2001-02-27 2002-02-21 Karbamatna jedinjenja za upotrebu u sprečavanju i lečenju bipolarnih poremećaja

Country Status (25)

Country Link
US (1) US7122576B2 (enExample)
EP (1) EP1368021B1 (enExample)
JP (1) JP4276839B2 (enExample)
KR (1) KR20030074849A (enExample)
CN (1) CN1250214C (enExample)
AT (1) ATE378046T1 (enExample)
AU (1) AU2002242226B2 (enExample)
BR (1) BR0207832A (enExample)
CA (1) CA2439292A1 (enExample)
CY (1) CY1107199T1 (enExample)
CZ (1) CZ296641B6 (enExample)
DE (1) DE60223506T2 (enExample)
DK (1) DK1368021T3 (enExample)
ES (1) ES2295320T3 (enExample)
HU (1) HUP0303261A3 (enExample)
IL (2) IL157589A0 (enExample)
MX (1) MXPA03007716A (enExample)
MY (1) MY133370A (enExample)
NO (1) NO20033799L (enExample)
NZ (1) NZ527989A (enExample)
PL (1) PL364640A1 (enExample)
PT (1) PT1368021E (enExample)
RS (1) RS50680B (enExample)
RU (1) RU2286147C2 (enExample)
WO (1) WO2002067924A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060194873A1 (en) * 2004-09-16 2006-08-31 Choi Yong M Methods of treating epileptogenesis and epilepsy
FR2884714B1 (fr) * 2005-04-20 2011-05-06 Servier Lab Utilisation de l'agomelatine pour l'obtention de medicaments destines au traitement des troubles bipolaires
US20070021501A1 (en) * 2005-07-12 2007-01-25 Twyman Roy E Methods of treating epileptogenesis
EP1928451B1 (en) * 2005-07-26 2011-12-28 SK Biopharmaceuticals Co., LTD Methods for treating substance-related disorders
EP2081648A2 (en) * 2006-10-30 2009-07-29 Janssen Pharmaceutica, N.V. Carbamate compounds for use in treating depression
HUP0700353A2 (en) * 2007-05-18 2008-12-29 Richter Gedeon Nyrt Metabolites of (thio)carbamoyl-cyclohexane derivatives
HUP0700370A2 (en) * 2007-05-24 2009-04-28 Richter Gedeon Nyrt Use of (thio)-carbamoyl-cyclohexane derivatives in the manufacture of a medicament for the treatment of acute mania
US7875610B2 (en) * 2007-12-03 2011-01-25 Richter Gedeon Nyrt. Pyrimidinyl-piperazines useful as D3/D2 receptor ligands
EP2251011B1 (en) * 2008-02-21 2012-04-04 Richter Gedeon Nyrt. Solid preparation for oral administration
SI2317852T1 (sl) 2008-07-16 2015-04-30 Richter Gedeon Nyrt. Farmacevtske formulacije, ki vsebujejo ligande dopaminskega receptorja
HU230067B1 (hu) 2008-12-17 2015-06-29 Richter Gedeon Nyrt Új piperazin só és eljárás előállítására
HUP0800766A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Vegyeszet Process for the preparation of piperazine derivatives
HUP0800765A2 (en) 2008-12-18 2010-11-29 Richter Gedeon Nyrt A new process for the preparation of piperazine derivatives and their hydrochloric salts
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
AU2017374458B2 (en) * 2016-12-14 2023-03-02 Sk Biopharmaceuticals Co., Ltd. Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3278380A (en) 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

Also Published As

Publication number Publication date
RU2003128996A (ru) 2005-03-10
YU68003A (sh) 2006-08-17
BR0207832A (pt) 2004-06-22
IL157589A0 (en) 2004-03-28
US20020193433A1 (en) 2002-12-19
CZ296641B6 (cs) 2006-05-17
EP1368021B1 (en) 2007-11-14
NZ527989A (en) 2005-12-23
NO20033799D0 (no) 2003-08-26
MY133370A (en) 2007-11-30
HUP0303261A3 (en) 2012-07-30
HUP0303261A2 (hu) 2004-01-28
HK1058762A1 (en) 2004-06-04
RU2286147C2 (ru) 2006-10-27
JP4276839B2 (ja) 2009-06-10
US7122576B2 (en) 2006-10-17
PT1368021E (pt) 2007-12-19
CN1503666A (zh) 2004-06-09
KR20030074849A (ko) 2003-09-19
JP2004525905A (ja) 2004-08-26
ES2295320T3 (es) 2008-04-16
WO2002067924A1 (en) 2002-09-06
IL157589A (en) 2009-09-22
CN1250214C (zh) 2006-04-12
DK1368021T3 (da) 2008-02-11
NO20033799L (no) 2003-09-10
AU2002242226B2 (en) 2006-06-29
MXPA03007716A (es) 2004-11-12
EP1368021A1 (en) 2003-12-10
DE60223506T2 (de) 2008-09-18
PL364640A1 (en) 2004-12-13
CZ20032312A3 (cs) 2004-06-16
DE60223506D1 (de) 2007-12-27
CY1107199T1 (el) 2012-11-21
ATE378046T1 (de) 2007-11-15
CA2439292A1 (en) 2002-09-06

Similar Documents

Publication Publication Date Title
RS50680B (sr) Karbamatna jedinjenja za upotrebu u sprečavanju i lečenju bipolarnih poremećaja
RS50677B (sr) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju bipolarnog poremaćaja
AU2002242226A1 (en) Carbamate compounds for use in preventing or treating bipolar disorder
RS50676B (sr) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja
AU2002255580B2 (en) Carbamate compounds for use in preventing or treating bipolar disorder
HK1058762B (en) Carbamate compounds for use in preventing or treating bipolar disorder
HK1063436B (en) Carbamate compounds for use in preventing or treating bipolar disorder
RS4504A (sr) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju neuropatskog bola u vezi sa klasterskim i migrenskim glavoboljama
AU2002255580A1 (en) Carbamate compounds for use in preventing or treating bipolar disorder
RS4604A (sr) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju neuropatskog bola u vezi sa klasterskim i migrenskim glavoboljama